The potential to use a patient's own cells to treat non-healing chronic wounds ? a serious complication of diabetes ? took an important step forward as researchers successfully reprogrammed skin cells taken from diabetic foot ulcers to form induced pluripotent stem cells (iPSCs). The reprogramming technique was similar in efficiency to the results achieved using healthy foot skin from non-diabetic patients.

Tufts Medical Center and Tufts University scientists have found new functions of the protein angiogenin (ANG) that play a significant role in the regulation of blood cell formation, important in bone marrow transplantation and recovery from radiation-induced bone marrow failure. Since current bone marrow transplantations have significant limitations, these discoveries may lead to important therapeutic interventions to help improve the effectiveness of these treatments.

A large nationwide study found that people who received transplants of cells collected from a donor's bone marrow ? the original source for blood stem cell transplants, developed decades ago ? had better self-reported psychological well-being, experienced fewer symptoms of graft-vs.-host disease and were more likely to be back at work five years after transplantation than those whose transplanted cells were taken from the donor's bloodstream.

On May 3, 2016, a group of 25 scientists from the Danish Stem Cell Center, (DanStem), visited the Danish high school

The authors investigated the influence of different serum supplementations on the skeletal myoblast ability to proliferate and differentiate during three-dimensional perfusion-based culture.

khoolase khabar